2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Resectable Pancreatic Ductal Adenocarcinoma: Is There a Difference Between Perioperative FOLFIRINOX vs. Gem / nab-P in Efficacy?

21 views
December 4, 2020
Comments 0
Login to view comments. Click here to Login